Summary Info	Regarding the CMB Approval for Allocated Capital Increase and Application to Borsa Istanbul for Determination of Sale Price
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Board Decision Date	09.10.2024
Authorized Capital (TL)	20.000.000.000
Paid-in Capital (TL)	1.016.031.947
Target Capital (TL)	1.016.031.947

Rights Issue (Allocated)

Share Group Info	Paid-in Capital (TL)	Amount of Private Placement Through Capital Increase By Restraining Preemptive Rights (TL)	Proportion of Private Placement Through Capital Increase By Restraining Preemptive Rights To The Capital (%)	New Shares'' ISIN	Form	Amount of Shares Cancelled (TL)
A Grubu, İşlem Görmüyor, TREAKFY00023	203.206.390
B Grubu, AKFYE, TREAKFY00015	812.825.557

	Paid-in Capital (TL)	Amount of Private Placement Through Capital Increase By Restraining Preemptive Rights (TL)	Proportion of Private Placement Through Capital Increase By Restraining Preemptive Rights To The Capital (%)	Amount of Shares Cancelled (TL)
TOTAL	1.016.031.947

The Person Increased Capital Devoted	Akfen International Holding B.V.
Total Sales Revenue Planned (TL) (*)	3.150.000.000

* The nominal capital increase amount to be raised is calculated according to the sale price of the share with a nominal value of 1 TL, which determined in line with Borsa Istanbul A.S.'s Procedure for Wholesale Purchase and Sale Transactions.

Other Aspects To Be Notified

Capital Market Board Application Date	25.09.2024
Capital Market Board Application Result	Approval
Capital Market Board Approval Date	21.11.2024
Property of Increased Capital Shares	Dematerialized Share

Additional Explanations

As announced in the Capital Markets Board (CMB) Bulletin dated November 21, 2024, numbered 2024/53:

A request for the approval of the issuance certificate by the CMB has been made regarding the following: within the framework of the procedure for Wholesale Trading Transactions of Borsa İstanbul A.Ş. (the Exchange), our company, Akfen Yenilenebilir Enerji A.Ş. (the Company) plans to increase its issued capital of 1,016,031,947 TL, which is within the registered capital ceiling of 20,000,000,000 TL. This increase will be made entirely in cash, with the rights of the existing shareholders to purchase new shares being completely restricted, and will result in a total sales revenue of 3,150,000,000 TL. The nominal amount of the shares to be issued will be determined based on the share sales price, which will be calculated per the procedure for Wholesale Trading Transactions of the Exchange. The newly issued shares will be allocated to Akfen International Holding B.V. by offsetting their cash receivables from the Company.

The CMB has resolved the following:
1. a) Considering that the nominal value of the shares subject to the capital increase will be determined after the Company submits its application to the Exchange, the share sales price should be set at no less than the base price calculated per the procedure for Wholesale Trading Transactions of the Exchange.
b) Based on the determined share sales price, the nominal value of the shares to be issued will be calculated, and the issuance certificate will be revised to include the nominal value and price information.

2. Akfen International Holding B.V. has committed that the shares to be issued will not be sold on the Exchange for one year from the date they are credited to the account at the Central Securities Depository (CSD). For off-Exchange sales, buyers of these shares will also be subject to the same restriction. Necessary procedures will be carried out, and information will be provided to the CSD accordingly.

In this context, an application was submitted to Borsa İstanbul A.Ş. today (November 22, 2024) to calculate the base price within the framework of the procedure for Wholesale Trading Transactions in order to determine the sales price.

Following the determination of the sales price, an application will be made to the Capital Markets Board for the approval of the issuance certificate, and the process for the allocated capital increase will proceed. Relevant disclosures will be shared with the public.

Respectfully announced to the public and investors.

This statement has been translated into English for informational purposes. In the event of any discrepancy between the Turkish and English versions of this disclosure statement, the Turkish version shall prevail.